Clinical characteristic and fecal microbiota responses to probiotic or antidepressant in patients with diarrhea-predominant irritable bowel syndrome with depression comorbidity: a pilot study

被引：1

作者：

Zhang Lu ^{[1
,2
,3
,4
]}

Liu YiXuan ^{[1
,2
,3
,4
]}

Wang Zhe ^{[5
,6
,7
,8
,9
,4
]}

Wang XiaoQi ^{[5
,6
,7
,8
,9
,4
]}

Zhang JingJing ^{[1
,2
,3
,4
]}

Jiang RongHuan ^{[10
,11
,8
,3
,4
,12
,13
,14
,4
]}

Wang XiangQun ^{[10
,11
,8
,3
,4
]}

Zhu ShiWei ^{[1
,2
,3
,4
]}

Wang Kun ^{[1
,2
,3
,4
]}

Liu ZuoJing ^{[1
,2
,3
,4
]}

Zhu HuaiQiu ^{[5
,6
,7
,8
,9
,4
]}

Duan LiPing

机构：

[1] DepartmentofGastroenterology,PekingUniversityThirdHospital,Beijing100191,ChinaDepartmentofGastroenterology,PekingUniversityThirdHospital,Beijing100191,ChinaDepartmentofBiomedicalEngineering,CollegeofEngineering,andCenterforQuantitativeBiology,PekingUnivers

[2] DepartmentofPsychologicalMedicine,ChinesePeople’sLiberationArmy(PLA)GeneralHospital,Beijing100853,ChinaDepartmentofPsychiatry,InstituteofMentalHealth,PekingUniversity,Beijing100191,ChinaDepartmentofGastroenterology,PekingUniversityThirdHospital,Beijing1001

来源：

中华医学杂志英文版 | 2019年 / 132卷 / 03期

关键词：

D O I：

暂无

中图分类号：

+ [];

学科分类号：

摘要：

<正>To the Editor: Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder that presents as abdominal pain with altered bowel habits. The pathophysiologic mechanism of IBS is no

引用

页码：346 / 347-348-349-350-351

共 50 条

[41] A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome
Chen, Chunqiu
Tao, Chunhua
Liu, Zhongchen
Lu, Meiling
Pan, Qiuhui
Zheng, Lijun
Li, Qing
Song, Zhenshun
Fichna, Jakub
PHYTOTHERAPY RESEARCH, 2015, 29 (11) : 1822 - 1827
[42] Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome
Li, Pingping
Zheng, Jimin
Bai, Yun
Wang, Dingxin
Cui, Zijin
Li, Yueqin
Zhang, Jian
Wang, Yuzhen
EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2020, 64 : 14 - 21
[43] Evaluation of Crofelemer in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome Patients
Mangel, Allen W.
Chaturvedi, Pravin
DIGESTION, 2008, 78 (04) : 180 - 186
[44] Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome Reply
Lembo, Anthony J.
GASTROENTEROLOGY, 2017, 152 (06) : 1630 - +
[45] Profiling the Adherent Mucosal and Luminal Microbiota in Diarrhea-Predominant Irritable Bowel Patients
Carroll, Ian M.
Chang, Young-Hyo
Sartor, R. Balfour
Ringel, Yehuda
GASTROENTEROLOGY, 2009, 136 (05) : A222 - A222
[46] Acupuncture for diarrhea-predominant irritable bowel syndrome: A randomized control study
Shen, Jiang-hong
Ye, Yong-ming
LI, Shan-shan
WORLD JOURNAL OF ACUPUNCTURE-MOXIBUSTION, 2022, 32 (02) : 123 - 130
[47] Fecal microbiota transplantation as a novel therapy for irritable bowel syndrome with predominant diarrhea
Aguilar, R. Cruz
Buch, T.
Bajbouj, M.
Schmid, R. M.
Wantia, N.
Thoeringer, C.
NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 : 110 - 110
[48] Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome
Wei, Wei
Wang, Hui-Fen
Zhang, Yu
Zhang, Yan-Li
Niu, Bing-Yu
Yao, Shu-Kun
WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (45) : 7153 - 7172
[49] Factorial study of moxibustion in treatment of diarrhea-predominant irritable bowel syndrome
Ji-Meng Zhao
Lu-Yi Wu
Hui-Rong Liu
Hong-Yi Hu
Jia-Ying Wang
Ren-Jia Huang
Yin Shi
Shan-Ping Tao
Qiang Gao
Ci-Li Zhou
Li Qi
Xiao-Peng Ma
Huan-Gan Wu
World Journal of Gastroenterology, 2014, (37) : 13563 - 13572
[50] Effects of an oral synbiotic on the gastrointestinal immune system and microbiota in patients with diarrhea-predominant irritable bowel syndrome
Adrian Mathias Moser
Walter Spindelboeck
Bettina Halwachs
Heimo Strohmaier
Patrizia Kump
Gregor Gorkiewicz
Christoph Högenauer
European Journal of Nutrition, 2019, 58 : 2767 - 2778

← 1 2 3 4 5 →